GLUE vs NRG · rev $123.7M vs P/E 145, rev $17.74B
Monte Rosa Therapeutics Inc (GLUE) versus NRG Energy Inc. (NRG) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
NRG Energy Inc. (NRG) is a utilities - independent power producers company listed on NYSE.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
Latest reported NRG revenue for 2026-06-30 was $17.74B. Net income was $631.0M. Revenue was up 72.9% from 2026-03-31 to 2026-06-30. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
GLUE currently screens at market cap $1.56B. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
Not investment advice. Open the GLUE and NRG stock pages for the full models.
Not investment advice.